Symbols / CAH Stock $195.85 +0.50% Cardinal Health, Inc.

Healthcare • Medical Distribution • United States • NYQ
CAH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Mr. Jason M. Hollar
Exch · Country NYQ · United States
Market Cap 45.87B
Enterprise Value 51.01B
Income 1.56B
Sales 250.74B
FCF (ttm) 4.85B
Book/sh -12.05
Cash/sh 16.81
Employees 53,084
Insider 10d —
IPO Aug 04, 1983
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 31.19%
P/E 29.95
Forward P/E 16.35
PEG 1.21
P/S 0.18
P/B -16.25
P/C —
EV/EBITDA 12.77
EV/Sales 0.20
Quick Ratio 0.42
Current Ratio 0.91
Debt/Eq —
LT Debt/Eq —
EPS (ttm) 6.54
EPS next Y 11.98
EPS Growth -19.50%
Revenue Growth 11.00%
EPS Gr Q/Q -21.10%
Rev Gr Q/Q —
Earnings (next) 2026-04-30
Earnings (prior) 2026-04-30
ROA 3.60%
ROE —
ROIC —
Gross Margin 3.76%
Oper. Margin 1.41%
Profit Margin 0.62%
Shs Outstand 234.21M
Shs Float 233.73M
Insider Own 0.26%
Instit Own 89.89%
Short Float 3.66%
Short Ratio 3.18
Short Interest 7.42M
52W High 233.60
vs 52W High -16.16%
52W Low 137.75
vs 52W Low 42.18%
Beta 0.54
Impl. Vol. 0.78%
Rel Volume 0.36
Avg Volume 2.02M
Volume 733.06K
Target (mean) $245.27
Tgt Median $245.00
Tgt Low $215.00
Tgt High $275.00
# Analysts 15
Recom Strong_buy
Prev Close $194.88
Price $195.85
Change 0.50%
About

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$245.27
Mean price target
2. Current target
$195.85
Latest analyst target
3. DCF / Fair value
$372.75
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$195.85
Low
$215.00
High
$275.00
Mean
$245.27

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-04 main JP Morgan Neutral → Neutral $215
2026-05-01 main Citigroup Buy → Buy $245
2026-05-01 main TD Cowen Buy → Buy $255
2026-05-01 main Wells Fargo Overweight → Overweight $245
2026-04-28 init William Blair — → Outperform —
2026-04-08 main Evercore ISI Group Outperform → Outperform $240
2026-02-24 main Barclays Overweight → Overweight $258
2026-02-10 main JP Morgan Neutral → Neutral $243
2026-02-10 main Wells Fargo Overweight → Overweight $256
2026-02-06 main Mizuho Outperform → Outperform $235
2026-01-29 main Morgan Stanley Overweight → Overweight $245
2026-01-15 main Wells Fargo Overweight → Overweight $237
2026-01-09 up Citigroup Neutral → Buy $244
2025-12-09 init Barclays — → Overweight $243
2025-11-05 main Wells Fargo Overweight → Overweight $221
2025-11-04 main Mizuho Outperform → Outperform $210
2025-11-03 main TD Cowen Buy → Buy $225
2025-10-31 main Citigroup Neutral → Neutral $190
2025-10-31 main UBS Buy → Buy $220
2025-10-31 main Evercore ISI Group Outperform → Outperform $220
News
RSS: Latest CAH news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 HALL PATRICIA HEMINGWAY Director — 381 $207.83 $79,183
2026-02-27 GREENE MICHELLE D Chief Technology Officer — 2,746 $228.47 $627,387
2026-02-18 ALT AARON E. Chief Financial Officer — 2,328 $225.50 $524,964
2026-02-06 HALL PATRICIA HEMINGWAY Director — 4,000 $229.72 $918,880
2026-01-15 PITTEROFF VALERIE CHRISTINE Officer — 3,982 $213.26 $849,201
2025-11-05 MUSSLEWHITE ROBERT W Director — 1,067 $0.00 $0
2025-11-05 KENNY GREGORY B Director — 1,702 $0.00 $0
2025-11-05 JOHRI AKHIL Director — 1,067 $0.00 $0
2025-11-05 HALL PATRICIA HEMINGWAY Director — 1,067 $0.00 $0
2025-11-05 KILLEFER NANCY Director — 1,067 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
222,578.00
-1.87%
226,827.00
+10.66%
204,979.00
+13.04%
181,326.00
Operating Revenue
222,578.00
-1.87%
226,827.00
+10.66%
204,979.00
+13.04%
181,326.00
Cost Of Revenue
214,410.00
-2.28%
219,413.00
+10.76%
198,105.00
+13.31%
174,842.00
Reconciled Cost Of Revenue
214,084.00
-2.24%
218,987.00
+10.77%
197,698.00
+13.31%
174,474.00
Gross Profit
8,168.00
+10.17%
7,414.00
+7.86%
6,874.00
+6.01%
6,484.00
Operating Expense
5,846.00
+10.64%
5,284.00
+3.91%
5,085.00
+5.15%
4,836.00
Selling General And Administration
5,382.00
+7.64%
5,000.00
+4.17%
4,800.00
+6.38%
4,512.00
Total Expenses
220,256.00
-1.98%
224,697.00
+10.58%
203,190.00
+13.09%
179,678.00
Operating Income
2,322.00
+9.01%
2,130.00
+19.06%
1,789.00
+8.56%
1,648.00
Total Operating Income As Reported
2,275.00
+83.02%
1,243.00
+65.29%
752.00
+223.89%
-607.00
EBITDA
3,106.00
+58.31%
1,962.00
+36.34%
1,439.00
+2516.36%
55.00
Normalized EBITDA
3,153.00
+10.67%
2,849.00
+15.06%
2,476.00
+6.82%
2,318.00
Reconciled Depreciation
790.00
+11.27%
710.00
+2.60%
692.00
+0.00%
692.00
EBIT
2,316.00
+84.98%
1,252.00
+67.60%
747.00
+217.27%
-637.00
Total Unusual Items
-47.00
+94.70%
-887.00
+14.46%
-1,037.00
+54.18%
-2,263.00
Total Unusual Items Excluding Goodwill
-47.00
+94.70%
-887.00
+14.46%
-1,037.00
+54.18%
-2,263.00
Special Income Charges
-47.00
+94.70%
-887.00
+14.46%
-1,037.00
+54.18%
-2,263.00
Other Special Charges
-185.00
-337.18%
78.00
+125.66%
-304.00
-392.31%
104.00
Impairment Of Capital Assets
—
634.00
-49.12%
1,246.00
-39.51%
2,060.00
Restructuring And Mergern Acquisition
214.00
+22.29%
175.00
+84.21%
95.00
-5.94%
101.00
Write Off
18.00
-97.16%
634.00
-49.12%
1,246.00
—
Net Income
1,561.00
+83.22%
852.00
+158.18%
330.00
+135.18%
-938.00
Pretax Income
2,101.00
+74.94%
1,201.00
+81.15%
663.00
+184.57%
-784.00
Net Non Operating Interest Income Expense
-215.00
-321.57%
-51.00
+39.29%
-84.00
+42.86%
-147.00
Interest Expense Non Operating
215.00
+321.57%
51.00
-39.29%
84.00
-42.86%
147.00
Net Interest Income
-215.00
-321.57%
-51.00
+39.29%
-84.00
+42.86%
-147.00
Interest Expense
215.00
+321.57%
51.00
-39.29%
84.00
-42.86%
147.00
Other Income Expense
-6.00
+99.32%
-878.00
+15.74%
-1,042.00
+54.40%
-2,285.00
Other Non Operating Income Expenses
41.00
+355.56%
9.00
+280.00%
-5.00
+77.27%
-22.00
Gain On Sale Of Business
—
0.00
0.00
-100.00%
2.00
Tax Provision
532.00
+52.87%
348.00
+4.82%
332.00
+116.99%
153.00
Tax Rate For Calcs
0.00
-12.69%
0.00
+37.98%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-11.89
+95.37%
-257.02
-18.02%
-217.77
+54.18%
-475.23
Net Income Including Noncontrolling Interests
1,569.00
+83.94%
853.00
+157.70%
331.00
+135.33%
-937.00
Net Income From Continuing Operation Net Minority Interest
1,561.00
+83.22%
852.00
+158.18%
330.00
+135.18%
-938.00
Net Income From Continuing And Discontinued Operation
1,561.00
+83.22%
852.00
+158.18%
330.00
+135.18%
-938.00
Net Income Continuous Operations
1,569.00
+83.94%
853.00
+157.70%
331.00
+135.33%
-937.00
Minority Interests
-8.00
-700.00%
-1.00
+0.00%
-1.00
+0.00%
-1.00
Normalized Income
1,596.11
+7.70%
1,481.98
+28.95%
1,149.23
+35.24%
849.77
Net Income Common Stockholders
1,561.00
+83.22%
852.00
+158.18%
330.00
+135.18%
-938.00
Diluted EPS
6.45
+86.96%
3.45
+245.00%
1.00
+129.85%
-3.35
Basic EPS
6.48
+86.21%
3.48
+248.00%
1.00
+129.85%
-3.35
Basic Average Shares
241.00
-1.63%
245.00
-6.13%
261.00
-6.45%
279.00
Diluted Average Shares
242.00
-2.02%
247.00
-5.73%
262.00
-6.09%
279.00
Diluted NI Availto Com Stockholders
1,561.00
+83.22%
852.00
+158.18%
330.00
+135.18%
-938.00
Amortization
464.00
+63.38%
284.00
-0.35%
285.00
-12.04%
324.00
Amortization Of Intangibles Income Statement
464.00
+63.38%
284.00
-0.35%
285.00
-12.04%
324.00
Depreciation Amortization Depletion Income Statement
464.00
+63.38%
284.00
-0.35%
285.00
-12.04%
324.00
Depreciation And Amortization In Income Statement
464.00
+63.38%
284.00
-0.35%
285.00
-12.04%
324.00
Gain On Sale Of PPE
—
-634.00
+49.28%
-1,250.00
+39.32%
-2,060.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
53,122.00
+17.73%
45,121.00
+4.09%
43,349.00
-1.21%
43,878.00
Current Assets
36,373.00
+4.27%
34,884.00
+3.40%
33,737.00
+2.44%
32,935.00
Cash Cash Equivalents And Short Term Investments
3,874.00
-24.53%
5,133.00
+25.93%
4,076.00
-13.59%
4,717.00
Cash And Cash Equivalents
3,874.00
-24.53%
5,133.00
+25.93%
4,076.00
-13.59%
4,717.00
Receivables
13,242.00
+9.58%
12,084.00
+8.79%
11,108.00
+5.18%
10,561.00
Accounts Receivable
13,242.00
+9.58%
12,084.00
+8.79%
11,108.00
+5.18%
10,561.00
Gross Accounts Receivable
13,455.00
+9.24%
12,317.00
+8.54%
11,348.00
+4.74%
10,834.00
Allowance For Doubtful Accounts Receivable
-213.00
+8.58%
-233.00
+2.92%
-240.00
+12.09%
-273.00
Inventory
16,831.00
+12.53%
14,957.00
-7.21%
16,119.00
+3.09%
15,636.00
Prepaid Assets
—
—
2,362.00
+16.87%
2,021.00
Assets Held For Sale Current
12.00
-74.47%
47.00
-66.43%
140.00
0.00
Other Current Assets
2,414.00
-9.35%
2,663.00
+16.09%
2,294.00
+13.51%
2,021.00
Total Non Current Assets
16,749.00
+63.61%
10,237.00
+6.50%
9,612.00
-12.16%
10,943.00
Net PPE
2,858.00
+13.01%
2,529.00
+2.76%
2,461.00
+4.24%
2,361.00
Gross PPE
7,516.00
+12.26%
6,695.00
+6.10%
6,310.00
+7.26%
5,883.00
Accumulated Depreciation
-4,658.00
-11.81%
-4,166.00
-8.24%
-3,849.00
-9.28%
-3,522.00
Properties
2,178.00
+15.91%
1,879.00
+5.03%
1,789.00
+3.77%
1,724.00
Land And Improvements
—
—
1,785.00
+3.54%
1,724.00
Machinery Furniture Equipment
4,761.00
+12.31%
4,239.00
+5.84%
4,005.00
+5.37%
3,801.00
Construction In Progress
577.00
+0.00%
577.00
+11.82%
516.00
+44.13%
358.00
Goodwill And Other Intangible Assets
12,177.00
+88.79%
6,450.00
+6.00%
6,085.00
-20.24%
7,629.00
Goodwill
9,269.00
+96.17%
4,725.00
+2.43%
4,613.00
-21.21%
5,855.00
Other Intangible Assets
2,908.00
+68.58%
1,725.00
+17.19%
1,472.00
-17.02%
1,774.00
Other Non Current Assets
1,714.00
+36.25%
1,258.00
+18.01%
1,066.00
+11.86%
953.00
Total Liabilities Net Minority Interest
55,756.00
+15.36%
48,333.00
+4.38%
46,306.00
+3.86%
44,584.00
Current Liabilities
38,897.00
+9.14%
35,640.00
+5.63%
33,740.00
+10.44%
30,550.00
Payables And Accrued Expenses
38,347.00
+8.92%
35,206.00
+6.99%
32,906.00
+9.80%
29,970.00
Payables
34,713.00
+9.30%
31,759.00
+6.10%
29,934.00
+10.34%
27,128.00
Accounts Payable
34,713.00
+9.30%
31,759.00
+6.10%
29,934.00
+10.34%
27,128.00
Current Accrued Expenses
3,634.00
+5.43%
3,447.00
+15.98%
2,972.00
+4.57%
2,842.00
Current Debt And Capital Lease Obligation
550.00
+26.73%
434.00
-45.20%
792.00
+36.55%
580.00
Current Debt
550.00
+26.73%
434.00
-45.20%
792.00
+36.55%
580.00
Other Current Liabilities
—
—
42.00
—
Total Non Current Liabilities Net Minority Interest
16,859.00
+32.82%
12,693.00
+1.01%
12,566.00
-10.46%
14,034.00
Long Term Debt And Capital Lease Obligation
7,977.00
+71.25%
4,658.00
+19.16%
3,909.00
-17.44%
4,735.00
Long Term Debt
7,977.00
+71.25%
4,658.00
+19.16%
3,909.00
-17.44%
4,735.00
Non Current Deferred Liabilities
—
—
8,653.00
-6.95%
9,299.00
Non Current Deferred Taxes Liabilities
—
—
8,653.00
-6.95%
9,299.00
Other Non Current Liabilities
8,882.00
+10.54%
8,035.00
-7.18%
8,657.00
-6.90%
9,299.00
Stockholders Equity
-2,781.00
+13.45%
-3,213.00
-8.62%
-2,958.00
-317.21%
-709.00
Common Stock Equity
-2,781.00
+13.45%
-3,213.00
-8.62%
-2,958.00
-317.21%
-709.00
Capital Stock
2,956.00
+1.34%
2,917.00
+6.23%
2,746.00
-2.38%
2,813.00
Common Stock
2,956.00
+1.34%
2,917.00
+6.23%
2,746.00
-2.38%
2,813.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
270.68
-17.22%
327.00
+0.00%
327.00
+0.00%
327.00
Ordinary Shares Number
238.68
-2.18%
244.00
-2.79%
251.00
-8.06%
273.00
Treasury Shares Number
32.00
-61.45%
83.00
+9.21%
76.00
+40.74%
54.00
Retained Earnings
783.00
+373.78%
-286.00
+55.45%
-642.00
-129.29%
-280.00
Gains Losses Not Affecting Retained Earnings
-155.00
+7.19%
-167.00
-10.60%
-151.00
-32.46%
-114.00
Treasury Stock
6,365.00
+12.12%
5,677.00
+15.60%
4,911.00
+57.00%
3,128.00
Minority Interest
147.00
+14600.00%
1.00
+0.00%
1.00
-66.67%
3.00
Other Equity Adjustments
-155.00
+7.19%
-167.00
-10.60%
-151.00
-32.46%
-114.00
Total Equity Gross Minority Interest
-2,634.00
+18.00%
-3,212.00
-8.62%
-2,957.00
-318.84%
-706.00
Total Capitalization
5,196.00
+259.58%
1,445.00
+51.95%
951.00
-76.38%
4,026.00
Working Capital
-2,524.00
-233.86%
-756.00
-25100.00%
-3.00
-100.13%
2,385.00
Invested Capital
5,746.00
+205.80%
1,879.00
+7.80%
1,743.00
-62.16%
4,606.00
Total Debt
8,527.00
+67.46%
5,092.00
+8.32%
4,701.00
-11.55%
5,315.00
Net Debt
4,653.00
—
625.00
+4.52%
598.00
Net Tangible Assets
-14,958.00
-54.80%
-9,663.00
-6.86%
-9,043.00
-8.46%
-8,338.00
Tangible Book Value
-14,958.00
-54.80%
-9,663.00
-6.86%
-9,043.00
-8.46%
-8,338.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
2,397.00
-36.28%
3,762.00
+32.28%
2,844.00
-10.43%
3,175.00
Cash Flow From Continuing Operating Activities
2,397.00
-36.28%
3,762.00
+32.28%
2,844.00
-10.43%
3,175.00
Net Income From Continuing Operations
1,569.00
+83.94%
853.00
+157.70%
331.00
+135.33%
-937.00
Depreciation Amortization Depletion
790.00
+11.27%
710.00
+2.60%
692.00
+0.00%
692.00
Depreciation And Amortization
790.00
+11.27%
710.00
+2.60%
692.00
+0.00%
692.00
Stock Based Compensation
244.00
+101.65%
121.00
+26.04%
96.00
+18.52%
81.00
Provisionand Write Offof Assets
53.00
+47.22%
36.00
-34.55%
55.00
+139.13%
23.00
Asset Impairment Charge
21.00
-96.70%
636.00
-49.24%
1,253.00
-39.88%
2,084.00
Deferred Tax
243.00
+333.65%
-104.00
-160.00%
-40.00
-385.71%
14.00
Deferred Income Tax
243.00
+333.65%
-104.00
-160.00%
-40.00
-385.71%
14.00
Operating Gains Losses
—
—
—
8.00
Change In Working Capital
-523.00
-134.64%
1,510.00
+230.42%
457.00
-62.23%
1,210.00
Change In Receivables
-833.00
+16.37%
-996.00
-4.84%
-950.00
+32.38%
-1,405.00
Changes In Account Receivables
-833.00
+16.37%
-996.00
-4.84%
-950.00
+32.38%
-1,405.00
Change In Inventory
-1,816.00
-262.87%
1,115.00
+370.63%
-412.00
+65.78%
-1,204.00
Change In Payables And Accrued Expense
2,126.00
+52.84%
1,391.00
-23.53%
1,819.00
-52.37%
3,819.00
Change In Accrued Expense
-606.00
-39.95%
-433.00
+56.57%
-997.00
-477.65%
264.00
Change In Payable
2,732.00
+49.78%
1,824.00
-35.23%
2,816.00
-20.79%
3,555.00
Change In Account Payable
2,732.00
+49.78%
1,824.00
-35.23%
2,816.00
-20.79%
3,555.00
Investing Cash Flow
-5,593.00
-202.49%
-1,849.00
-307.27%
-454.00
-180.07%
567.00
Cash Flow From Continuing Investing Activities
-5,593.00
-202.49%
-1,849.00
-307.27%
-454.00
-180.07%
567.00
Net PPE Purchase And Sale
-547.00
-7.05%
-511.00
-6.24%
-481.00
-35.11%
-356.00
Purchase Of PPE
-547.00
-7.05%
-511.00
-6.24%
-481.00
-24.29%
-387.00
Sale Of PPE
—
12.00
+0.00%
12.00
-61.29%
31.00
Capital Expenditure
-547.00
-7.05%
-511.00
-6.24%
-481.00
-24.29%
-387.00
Net Investment Purchase And Sale
202.00
+221.69%
-166.00
-672.41%
29.00
+31.82%
22.00
Purchase Of Investment
0.00
+100.00%
-550.00
0.00
+100.00%
-78.00
Sale Of Investment
202.00
-47.40%
384.00
+1224.14%
29.00
-71.00%
100.00
Net Business Purchase And Sale
-5,250.00
-341.18%
-1,190.00
-11800.00%
-10.00
-101.11%
901.00
Purchase Of Business
-5,250.00
-341.18%
-1,190.00
-11800.00%
-10.00
+54.55%
-22.00
Gain Loss On Sale Of Business
—
0.00
0.00
+100.00%
-2.00
Net Other Investing Changes
2.00
-88.89%
18.00
+125.00%
8.00
—
Financing Cash Flow
1,940.00
+329.04%
-847.00
+72.24%
-3,051.00
-23.87%
-2,463.00
Cash Flow From Continuing Financing Activities
1,940.00
+329.04%
-847.00
+72.24%
-3,051.00
-23.87%
-2,463.00
Net Issuance Payments Of Debt
3,224.00
+805.62%
356.00
+161.49%
-579.00
+34.58%
-885.00
Issuance Of Debt
3,669.00
+222.12%
1,139.00
0.00
0.00
Repayment Of Debt
-445.00
+43.17%
-783.00
-35.23%
-579.00
+34.58%
-885.00
Long Term Debt Issuance
3,669.00
+222.12%
1,139.00
0.00
0.00
Long Term Debt Payments
-445.00
+43.17%
-783.00
-35.23%
-579.00
+34.58%
-885.00
Net Long Term Debt Issuance
3,224.00
+805.62%
356.00
+161.49%
-579.00
+34.58%
-885.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
-765.00
-2.00%
-750.00
+62.50%
-2,000.00
-100.00%
-1,000.00
Common Stock Payments
-765.00
-2.00%
-750.00
+62.50%
-2,000.00
-100.00%
-1,000.00
Common Stock Dividend Paid
-494.00
+1.00%
-499.00
+4.95%
-525.00
+6.08%
-559.00
Cash Dividends Paid
-494.00
+1.00%
-499.00
+4.95%
-525.00
+6.08%
-559.00
Repurchase Of Capital Stock
-765.00
-2.00%
-750.00
+62.50%
-2,000.00
-100.00%
-1,000.00
Net Other Financing Charges
-25.00
-154.35%
46.00
-13.21%
53.00
+378.95%
-19.00
Changes In Cash
-1,256.00
-217.82%
1,066.00
+261.27%
-661.00
-151.68%
1,279.00
Effect Of Exchange Rate Changes
-3.00
+66.67%
-9.00
-12.50%
-8.00
+68.00%
-25.00
Beginning Cash Position
5,133.00
+25.93%
4,076.00
-14.10%
4,745.00
+40.30%
3,382.00
End Cash Position
3,874.00
-24.53%
5,133.00
+25.93%
4,076.00
-14.10%
4,745.00
Free Cash Flow
1,850.00
-43.09%
3,251.00
+37.58%
2,363.00
-15.24%
2,788.00
Interest Paid Supplemental Data
315.00
+47.20%
214.00
+5.42%
203.00
+32.68%
153.00
Income Tax Paid Supplemental Data
444.00
+132.46%
191.00
+22.44%
156.00
—
Earnings Losses From Equity Investments
—
—
—
—
Other Cash Adjustment Outside Changein Cash
—
0.00
0.00
-100.00%
109.00
Sale Of Business
—
9.00
0.00
-100.00%
923.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category